2010-2

摘要

Datamonitor's Pharmaceuticals: United States Industry Guide is an essential resource for top-level data and analysis covering the United States Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis with distinct chapters for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals

Scope of the Report
 
* Contains an executive summary and data on value, volume and segmentation for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals
 
* Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Includes five-year forecasts for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals

Highlights

* The US pharmaceuticals market generated total revenues of $276,681.9 million in 2009, representing a compound annual growth rate (CAGR) of 2.8% for the period spanning 2005-2009.

* The United States OTC pharmaceuticals market generated total revenues of $23.6 billion in 2008, representing a compound annual growth rate (CAGR) of 3.3% for the period spanning 2004-2008.

* The US biotechnology market generated total revenues of $91.9 billion in 2008, representing a compound annual growth rate (CAGR) of 12.7% for the period spanning 2004-2008.

* The US generics market generated total revenues of $105.4 billion in 2008, representing a compound annual growth rate (CAGR) of 10.4% for the period spanning 2004-2008.

Why you should buy this report
 
* Spot future trends and developments
 
* Inform your business decisions
 
* Add weight to presentations and marketing materials
 
* Save time carrying out entry-level research

目录及图表

TABLE OF CONTENTS
CHAPTER 1 BIOTECHNOLOGY IN THE UNITED STATES 10
1.1 Market Overview 10
1.2 Market Value 12
1.3 Market Segmentation I 13
1.4 Market Segmentation II 14
1.5 Five Forces Analysis 15
1.6 Market Forecasts 21
CHAPTER 2 GENERICS IN THE UNITED STATES 22
2.1 Market Overview 22
2.2 Market Value 24
2.3 Market Segmentation I 25
2.4 Market Segmentation II 26
2.5 Five Forces Analysis 27
2.6 Market Forecasts 35
CHAPTER 3 OTC PHARMACEUTICALS IN THE UNITED STATES  36
3.1 Market Overview 36
3.2 Market Value 38
3.3 Market Segmentation I 39
3.4 Market Segmentation II 40
3.5 Market Share 41
3.6 Five Forces Analysis 42
3.7 Distribution 50
3.8 Market Forecasts 51
CHAPTER 4 PHARMACEUTICALS IN THE UNITED STATES 52
4.1 Market Overview 52
4.2 Market Value 54
4.3 Market Segmentation I 55
4.4 Market Segmentation II 56
4.5 Market Share 57
4.6 Five Forces Analysis 58
4.7 Market Forecasts 65
CHAPTER 5 MACROECONOMIC INDICATORS 66
CHAPTER 6 APPENDIX 67
6.1 Data Research Methodology 67

 
LIST OF TABLES
Table 1: United States Biotechnology Market Value: $ billion, 2004-2008 12
Table 2: United States Biotechnology Market Segmentation I: % Share, by Value, 2008 13
Table 3: United States Biotechnology Market Segmentation II: % Share, by Value, 2008 14
Table 4: United States Biotechnology Market Value Forecast: $ billion, 2008-2013 21
Table 5: United States Generics Market Value: $ billion, 2004-2008 24
Table 6: United States Generics Market Segmentation I: % Share, by Value, 2008 25
Table 7: United States Generics Market Segmentation II: % Share, by Value, 2008 26
Table 8: United States Generics Market Value Forecast: $ billion, 2008-2013 35
Table 9: United States OTC Pharmaceuticals Market Value: $ billion, 2004-2008 38
Table 10: United States OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008 39
Table 11: United States OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008 40
Table 12: United States OTC Pharmaceuticals Market Share: % Share, by Value, 2008 41
Table 13: United States OTC Pharmaceuticals Distribution: % Share, by Value, 2008 50
Table 14: United States OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 51
Table 15: United States Pharmaceuticals Market Value: $ billion, 2005-2009 54
Table 16: United States Pharmaceuticals Market Segmentation I: % Share, by Value, 2009 55
Table 17: United States Pharmaceuticals Market Segmentation II: % Share, by Value, 2009 56
Table 18: United States Pharmaceuticals Market Share: % Share, by Value, 2009 57
Table 19: United States Pharmaceuticals Market Value Forecast: $ billion, 2009-2014 65
Table 20: United States Size of Population (million) , 2004-2008 66
Table 21: United States GDP (Constant 2000 Prices, $ billion), 2004-2008 66
Table 22: United States Inflation, 2004-2008 66

 
LIST OF FIGURES
Figure 1: United States Biotechnology Market Value: $ billion, 2004-2008 12
Figure 2: United States Biotechnology Market Segmentation I: % Share, by Value, 2008 13
Figure 3: United States Biotechnology Market Segmentation II: % Share, by Value, 2008 14
Figure 4: Forces Driving Competition in the Biotechnology Market in the United States, 2008 15
Figure 5: Drivers of Buyer Power in the Biotechnology Market in the United States, 2008 16
Figure 6: Drivers of Supplier Power in the Biotechnology Market in the United States, 2008 17
Figure 7: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in the United States, 2008 18
Figure 8: Factors Influencing the Threat of Substitutes in the Biotechnology Market in the United States, 2008 19
Figure 9: Drivers of Degree of Rivalry in the Biotechnology Market in the United States, 2008 20
Figure 10: United States Biotechnology Market Value Forecast: $ billion, 2008-2013 21
Figure 11: United States Generics Market Value: $ billion, 2004-2008 24
Figure 12: United States Generics Market Segmentation I: % Share, by Value, 2008 25
Figure 13: United States Generics Market Segmentation II: % Share, by Value, 2008 26
Figure 14: Forces Driving Competition in the Generics Market in the United States, 2008 27
Figure 15: Drivers of Buyer Power in the Generics Market in the United States, 2008 29
Figure 16: Drivers of Supplier Power in the Generics Market in the United States, 2008 30
Figure 17: Factors Influencing the Likelihood of New Entrants in the Generics Market in the United States, 2008 31
Figure 18: Factors Influencing the Threat of Substitutes in the Generics Market in the United States, 2008 32
Figure 19: Drivers of Degree of Rivalry in the Generics Market in the United States, 2008 34
Figure 20: United States Generics Market Value Forecast: $ billion, 2008-2013 35
Figure 21: United States OTC Pharmaceuticals Market Value: $ billion, 2004-2008 38
Figure 22: United States OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008 39
Figure 23: United States OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008 40
Figure 24: United States OTC Pharmaceuticals Market Share: % Share, by Value, 2008 41
Figure 25: Forces Driving Competition in the OTC Pharmaceuticals Market in the United States, 2008 42
Figure 26: Drivers of Buyer Power in the OTC Pharmaceuticals Market in the United States, 2008 44
Figure 27: Drivers of Supplier Power in the OTC Pharmaceuticals Market in the United States, 2008 45
Figure 28: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in the United States, 2008 46
Figure 29: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in the United States, 2008 48
Figure 30: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in the United States, 2008 49
Figure 31: United States OTC Pharmaceuticals Distribution: % Share, by Value, 2008 50
Figure 32: United States OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 51
Figure 33: United States Pharmaceuticals Market Value: $ billion, 2005-2009 54
Figure 34: United States Pharmaceuticals Market Segmentation I: % Share, by Value, 2009 55
Figure 35: United States Pharmaceuticals Market Segmentation II: % Share, by Value, 2009 56
Figure 36: United States Pharmaceuticals Market Share: % Share, by Value, 2009 57
Figure 37: Forces Driving Competition in the Pharmaceuticals Market in the United States, 2009 58
Figure 38: Drivers of Buyer Power in the Pharmaceuticals Market in the United States, 2009 60
Figure 39: Drivers of Supplier Power in the Pharmaceuticals Market in the United States, 2009 61
Figure 40: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in the United States, 2009 62
Figure 41: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in the United States, 2009 63
Figure 42: Drivers of Degree of Rivalry in the Pharmaceuticals Market in the United States, 2009 64
Figure 43: United States Pharmaceuticals Market Value Forecast: $ billion, 2009-2014 65